Digital breast tomosynthesis screening ‘ups invasive investigations’
The 3D modality finds both more malignant and more benign lesions than digital mammography, study shows.
The 3D modality finds both more malignant and more benign lesions than digital mammography, study shows.
Among patients with early breast cancer undergoing ovarian suppression, aromatase inhibitors cut tumour recurrence by a third, data show.
Insulin resistance triggers exosomes to deliver more cancer-linked proteins to the malignant cells, research shows.
The issue translates into poorer survival for some women with early breast cancer, researchers say.
This article marks Breast Reconstruction Awareness Day on 20 October 2021. A few weeks ago, I was sitting in a hospital bed recovering from major surgery. I had four tubes and…
A retrospective study of Australian patients under intense surveillance because of germline mutations shows the exams don’t improve cancer detect…
Patients with inherited genetic mutations may be more responsive to chemotherapy, researchers say.
But more research is needed on how to utilise the information from screening without alarming patients, authors say.
Results are strong evidence against routine extended use in women with hormone-receptor positive disease, expert says.
Canadian data differs from results seen in the CLEOPATRA and EMILIA trials, researchers report.
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.